HOME › DRUGS › LEMBOREXANT
ACTIVE SUBSTANCE / INN

LEMBOREXANT

Brand name(s): DAYVIGO
FDA LISTED
PRESCRIPTION
NDA212028
ACTIVE SUBSTANCE
Lemborexant
REGULATORS
FDA
SPONSORS / MAH
EISAI INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DAYVIGONDA212028EISAI INCPrescription

FULL INTELLIGENCE ON LEMBOREXANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →